Barry Schweitzer, PhD, D’82 joined Dartmouth’s Magnuson Center for Entrepreneurship in 2021 after serving as Senior Business Development and Licensing Manager in the College’s Technology Transfer Office from 2019. Barry returned to Dartmouth after 20+ years of experience in management and leadership positions in the biotech industry, most recently as a Venture Partner at Elm Street Ventures, a seed and early-stage venture capital firm based in New Haven, CT, where he led investments in the life sciences. He also served on the board of the Elm City Innovation Collaborative, an organization supported by the State of Connecticut to promote, connect, and enable New Haven’s diverse innovation ecosystem, and was an Entrepreneur in Residence at Yale University and the University of Connecticut. A serial entrepreneur, Barry was co-founder and CEO of Glygenix Therapeutics, Inc., a gene therapy company, and helped to start up several Yale biotech spin-off companies that were eventually acquired by global life sciences companies. Prior to entering the biotechnology industry, Barry was an Assistant Professor in the Department of Chemistry at the University of Central Florida, a Leukemia Society Special Fellow at Yale University School of Medicine, and a post-doctoral fellow at the Memorial Sloan-Kettering Cancer Institute. He received his PhD in Pharmacology from Yale and his Bachelor’s degree in Biology from Dartmouth College in 1982, and is an author on over 50 peer-reviewed scientific publications, reviews, and patents.

Dr. Schweitzer’s LinkedIn page